Vaxart has received approval from the Biomedical Advanced Research and Development Authority (BARDA) to initiate dosing in the 10,000-participant portion of its Phase 2b clinical trial evaluating its oral pill COVID-19 vaccine candidate.
Learn more: https://t.co/IV1t1ysZak
$VXRT